As of the latest Form 4 filed Jun 24, 2026.
What Nuvation Bio Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 15 most recent filings for NUVB.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-24 | 2026-06-23 | Sauvage Philippe Chief Financial Officer | SSale | −47.7K | $6.01 | $286K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Sauvage Philippe, Chief Financial Officer | MExercise | +47.7K | $2.17 | $103K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Markel Stacy CHIEF PEOPLE OFFICER | SSale | −125K | $6.03 | $753K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Markel Stacy, CHIEF PEOPLE OFFICER | MExercise | +34.6K | $1.74 | $60.2K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Markel Stacy, CHIEF PEOPLE OFFICER | MExercise | +90.4K | $1.87 | $169K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Wentworth Kerry CHIEF REGULATORY OFFICER | SSale | −63.0K | $6.02 | $379K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Wentworth Kerry, CHIEF REGULATORY OFFICER | MExercise | +63.0K | $2.93 | $185K | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Mashal Robert Director | PPurchase | +25.0K | $4.73 | $118K | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Liu Dongfang CHIEF MEDICAL OFFICER | SSale | −50.0K | $5.02 | $251K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Liu Dongfang, CHIEF MEDICAL OFFICER | MExercise | +50.0K | $1.94 | $97.0K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Wentworth Kerry CHIEF REGULATORY OFFICER | SSale | −36.8K | $5.01 | $184K | Yes (planned) | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | Wentworth Kerry, CHIEF REGULATORY OFFICER | MExercise | +36.8K | $2.93 | $108K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Wentworth Kerry CHIEF REGULATORY OFFICER | SSale | −200K | $4.52 | $904K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Wentworth Kerry, CHIEF REGULATORY OFFICER | MExercise | +100K | $1.94 | $194K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Wentworth Kerry, CHIEF REGULATORY OFFICER | MExercise | +100K | $1.87 | $187K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also NUVB’s full analysis or the market-wide insider trading feed. The tabs above jump to NUVB’s other SEC data.
Source: SEC Form 4 filings for NUVB, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.